Eagle Pharmaceuticals
EGRX · OTC
$0.885−$0.705 (−44.34%)TodayMarket closed ·
Prev close $1.59
Who owns EGRX
Largest institutional holders, from their latest 13F filings
The 5 largest institutions hold 43.3% of EGRX’s shares.
- Nantahala Capital Management, LLC38.1%
- J. Goldman & Co., L.P.5.1%
- Stanley-Laman Group, Ltd.0.1%
- BlackRock Fund Advisors0.0%
- Next 1 largest institutions0.0%
- All other shareholders56.7%
| Holder | Shares | % of shares |
|---|---|---|
| Nantahala Capital Management, LLC | 4.95M | 38.07% |
| J. Goldman & Co., L.P. | 667.11K | 5.14% |
| Stanley-Laman Group, Ltd. | 12.00K | 0.09% |
| BlackRock Fund Advisors | 2.31K | 0.02% |
| Archer Investment Corporation | 350 | 0.00% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| BlackRock Diversified Equity Alpha Fund | 2.31K | 0.02% |
Short interest
Settled Sep 30, 2026
- Shares short
- 33.83K
- Days to cover
- 5.79
- % of shares outstanding
- 0.26%
- Average daily volume
- 5.84K
- Change since last report
- −19.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.